We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global POC Molecular Diagnostics Market Driven by Increasing Demand for Rapid and Accurate Testing

By LabMedica International staff writers
Posted on 20 Jun 2023

The demand for rapid and accurate diagnostic techniques has witnessed a surge, resulting in increased demand for point of care (POC) molecular diagnostics due to its numerous benefits. More...

These include quick turnaround times, portability, and the capacity to deliver results in the patient's immediate surroundings or in settings with limited resources. There is tremendous potential in POC molecular diagnostics to transform healthcare delivery by offering quick and accurate diagnosis at the point of need. Thus, significant growth and advancements in the global POC molecular diagnostics market are anticipated in the coming years. The global POC molecular diagnostics market is projected to register a compound annual growth rate (CAGR) of 10.6% from about USD 2 billion in 2023 to USD 3.4 billion in 2028. The market growth will be primarily driven by the rising occurrence of infectious diseases and cancer, increasing emphasis on decentralized diagnostics, surge in R&D funding, growing awareness about early infection detection, and high utilization of POC diagnostic tests.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a market research firm.

The development of more compact and user-friendly devices is likely in the POC molecular diagnostics market. These devices will have the ability to detect a wide range of diseases, including infectious diseases, genetic disorders, and cancer, with high sensitivity and specificity. These advancements will enable healthcare providers to make timely and informed treatment decisions, leading to improved patient outcomes. Additionally, the integration of artificial intelligence and machine learning algorithms into POC molecular diagnostics platforms will enhance diagnostic accuracy and interpretation of results. The market growth will also be fueled by the increasing prevalence of infectious diseases, the need for decentralized testing, and a growing focus on personalized medicine.

Based on products & services, the assays & kits segment held the largest share of the POC molecular diagnostics market in 2022. Assays & kits are widely utilized in various POC settings such as hospital critical care units, physicians' offices, outpatient clinics, home care settings, and long-term care settings. The continuous demand and recurring purchases of assays & kits are anticipated to fuel the segment’s growth and consequently, that of the POC molecular diagnostics market. On the basis of technology, the RT-PCR segment accounted for the largest share of the POC molecular diagnostics market in 2022. This can be attributed to the fact that RT-PCR is one of the most widely used technologies in diagnostics due to its ease of use, cost-effectiveness, and quick turnaround time (4 to 6 hours).

Based on end user, the physicians' offices segment held the largest share of the POC molecular diagnostics market in 2022. POC molecular assay & kits and systems are widely utilized in these settings because they offer rapid results within 30 minutes. This aids in immediate diagnosis, enabling physicians to swiftly diagnose or monitor a patient's condition. Based on application, the respiratory diseases segment had the largest share in the POC molecular diagnostics market in 2022 due to the rising prevalence of infectious diseases and the increasing demand for early detection and diagnosis of these diseases. This is particularly relevant in emerging nations, where the need to tackle the challenges of infectious diseases through timely and accurate molecular diagnostics is more prominent.

Geographically, North America dominated the global POC molecular diagnostics market in 2022 with the largest share, which can be attributed to the highly advanced healthcare system in the region and the high burden of infectious diseases and cancers on regional healthcare systems. Recent years have seen a marked increase in healthcare spending across North America. National health spending is projected to grow at an average annual rate of 5.4% from 2019 to 2028, reaching an astounding USD 6.2 trillion by 2028, as per the Centers for Medicare & Medicaid Services. This surge in healthcare expenditure is a crucial driver for the growth of the North American POC molecular diagnostics market. The presence of a well-developed healthcare infrastructure and the growing adoption of advanced technologies for infectious disease testing will further support the growth of the POC molecular diagnostics market in North America.

Related Links:
MarketsandMarkets 


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.